A clinician's guide to effects of obesity on childhood asthma and into adulthood

被引:0
|
作者
Abu Zahra, Mahmoud [1 ]
Pessin, Jeffrey [2 ]
Rastogi, Deepa [1 ,3 ]
机构
[1] Albert Einstein Coll Med, Dept Pediat, Div Resp & Sleep Med, Bronx, NY USA
[2] Albert Einstein Coll Med, Dept Med, Bronx, NY USA
[3] Albert Einstein Coll Med, Norman Fle Inst Diabet & Metab, Bronx, NY USA
基金
美国国家卫生研究院;
关键词
Asthma; obesity; children; adults; disease burden; therapies; AIRWAY SMOOTH-MUSCLE; BODY-MASS INDEX; NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; CD4(+) T-CELLS; LUNG-FUNCTION; PULMONARY-FUNCTION; BARIATRIC SURGERY; WEIGHT-LOSS; SYSTEMIC INFLAMMATION;
D O I
10.1080/17476348.2024.2403500
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
IntroductionObesity, one of the most common chronic conditions affecting the human race globally, affects several organ systems, including the respiratory system, where it contributes to onset and high burden of asthma. Childhood onset of obesity-related asthma is associated with high persistent morbidity into adulthood.Areas coveredIn this review, we discuss the disease burden in children and adults to highlight the overlap between symptoms and pulmonary function deficits associated with obesity-related asthma in both age ranges, and then discuss the potential role of three distinct mechanisms, that of mechanical fat load, immune perturbations, and of metabolic perturbations on the disease burden. We also discuss interventions, including medical interventions for weight loss such as diet modification, that of antibiotics and anti-inflammatory therapies, as well as that of surgical intervention on amelioration of burden of obesity-related asthma.Expert opinionWith increase in obesity-related asthma due to increasing burden of obesity, it is evident that it is a disease entity distinct from asthma among lean individuals. The time is ripe to investigate the underlying mechanisms, focusing on identifying novel therapeutic targets as well as consideration to repurpose medications effective for other obesity-mediated complications, such as insulin resistance, dyslipidemia and systemic inflammation.
引用
收藏
页码:759 / 775
页数:17
相关论文
共 50 条